Replimune Group, Inc.
For the period ended Mar 31, 2026. Filed Jun 29, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jun 29, 2026
REPL$21.62+8.0%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated statements of operations F-
CONSOLIDATED STATEMENTS OF OPERATIONS
| Year Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating expenses: | ||
| Research and development | $221,184 | $189,447 |
| Selling, general and administrative | 98,735 | 72,180 |
| Total operating expenses | 319,919 | 261,627 |
| Loss from operations | (319,919) | (261,627) |
| Other income (expense): | ||
| Research and development incentives | 1,604 | 1,773 |
| Investment income | 13,625 | 21,120 |
| Interest expense on finance lease liability | (2,063) | (2,118) |
| Interest expense on debt obligations | (6,796) | (5,775) |
| Other expense | (942) | (202) |
| Total other income, net | 5,428 | 14,798 |
| Loss before income taxes | $(314,491) | $(246,829) |
| Income tax (benefit) provision | (551) | 468 |
| Net loss | $(313,940) | $(247,297) |
| Net loss per common share, basic and diluted | $(3.38) | $(3.07) |
| Weighted average common shares outstanding, basic and diluted | 92,803,711 | 80,564,147 |
F - 5
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.